CVC Explores Options for €11 Billion Drugmaker Recordati
CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.
CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.
Kering SA shares tumbled after the luxury group warned that profit will plunge in the first half of the year on slumping sales at Gucci, its biggest brand.
Some of the world’s biggest energy trading companies are returning to metals, years after getting burnt in the notoriously difficult markets.
China is moving to curb “snowball” derivatives after brokers hiked returns to near-record levels to attract investors to the risky products following a stock-market selloff, according to people familiar with the matter.
The Middle East’s biggest alternative asset manager is setting up a $1 billion investment vehicle backed by Beijing’s sovereign wealth fund to invest in companies across the Persian Gulf and China.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}